Kunming Baker Norton Pharmaceutical Sales Co., Ltd.
Quick facts
Marketed products
- DICL-SR · Rheumatology / Pain Management
DICL-SR is a sustained-release formulation of diclofenac that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and provide anti-inflammatory, analgesic, and antipyretic effects.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Kunming Baker Norton Pharmaceutical Sales Co., Ltd. portfolio CI brief
- Kunming Baker Norton Pharmaceutical Sales Co., Ltd. pipeline updates RSS
Frequently asked questions about Kunming Baker Norton Pharmaceutical Sales Co., Ltd.
What are Kunming Baker Norton Pharmaceutical Sales Co., Ltd.'s marketed drugs?
Top marketed products include DICL-SR.
Related
- DICL-SR · Rheumatology / Pain Management
- Sector hub: All tracked pharma companies